Modern approach to metabolic rehabilitation of cancer patients: biguanides (phenformin and metformin) and beyond (Q37783621)

23 August 2017

Modern approach to metabolic rehabilitation of cancer patients: biguanides (phenformin and metformin) and beyond (English)

1 reference

23 August 2017

0 references

1 reference

Lev M Berstein

1

1 reference

PubMed ID

20799876

23 August 2017

language of work or name

English

0 references

publication date

1 August 2010

1 reference

23 August 2017

1 reference

23 August 2017

6

1 reference

23 August 2017

1313-1323

1 reference

23 August 2017

8

1 reference

Metabolic immunodepression which increases the risk of cancer

23 August 2017

1 reference

Neoadjuvant endocrine therapy for breast cancer: past, present and future

21 January 2018

1 reference

Clinical, pathological, proliferative and molecular responses associated with neoadjuvant aromatase inhibitor treatment in breast cancer

21 January 2018

1 reference

Prevention of cancer by inhibiting aging

21 January 2018

1 reference

Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer

21 January 2018

1 reference

Clinical implications for statin pleiotropy

21 January 2018

1 reference

Influence of obesity on breast cancer receptor status and prognosis

21 January 2018

1 reference

Mechanisms of acquired resistance to endocrine therapy in hormone-dependent breast cancer cells

21 January 2018

1 reference

Biological determinants of endocrine resistance in breast cancer

21 January 2018

1 reference

Metabolic complications of androgen deprivation therapy for prostate cancer

21 January 2018

1 reference

The frequency, magnitude and timing of post-diagnosis body weight gain in Dutch breast cancer survivors.

21 January 2018

1 reference

Body mass index: relationship to clinical, pathologic and features of microsatellite instability in endometrial cancer

21 January 2018

1 reference

Advanced glycation end products and insulin resistance

21 January 2018

1 reference

Obesity and cancer: the role of dysfunctional adipose tissue

21 January 2018

1 reference

On the Origin of Cancer Cells

21 January 2018

1 reference

Glucose metabolism and cancer

21 January 2018

1 reference

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

21 January 2018

1 reference

Mitochondria in cancer cells: what is so special about them?

21 January 2018

1 reference

The LKB1-AMPK pathway: metabolism and growth control in tumour suppression

21 January 2018

1 reference

Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission

21 January 2018

1 reference

Pharmacogenetics and breast cancer endocrine therapy: CYP2D6 as a predictive factor for tamoxifen metabolism and drug response?

21 January 2018

1 reference

Pharmacogenetics of thiazolidinedione therapy

21 January 2018

1 reference

Pharmacogenetics of metformin response: a step in the path toward personalized medicine

21 January 2018

1 reference

Endocrinology of the wild and mutant BRCA1 gene and types of hormonal carcinogenesis

21 January 2018

1 reference

Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research.

21 January 2018

1 reference

Insulin and insulin-like growth factor signalling in neoplasia

21 January 2018

1 reference

Thyrotropin Suppression by Metformin

21 January 2018

1 reference

Insulin-lowering effects of metformin in women with early breast cancer

21 January 2018

1 reference

Energy intake, physical activity, energy balance, and cancer: epidemiologic evidence

21 January 2018

1 reference

Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study

21 January 2018

1 reference

Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature

21 January 2018

1 reference

Identifying population-based approaches to lower breast cancer risk

21 January 2018

1 reference

Pleiotropic effects of thiazolidinediones on traditional and non-traditional atherosclerotic risk factors

21 January 2018

1 reference

Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines.

21 January 2018

1 reference

Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro

21 January 2018

1 reference

Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice

21 January 2018

1 reference

Breast cancer growth prevention by statins

21 January 2018

1 reference

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

21 January 2018

1 reference

21 January 2018

1 reference

Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice

21 January 2018

1 reference

Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention

21 January 2018

1 reference

Statins and cancer: A systematic review and meta-analysis

21 January 2018

1 reference

Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer

21 January 2018

1 reference

Troglitazone enhances tamoxifen-induced growth inhibitory activity of MCF-7 cells

21 January 2018

1 reference

Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System

21 January 2018

1 reference

Targeting of cancer energy metabolism.

21 January 2018

1 reference

The antiobesity drug Orlistat induces cytotoxic effects, suppresses Her-2/neu (erbB-2) oncogene overexpression, and synergistically interacts with trastuzumab (Herceptin) in chemoresistant ovarian cancer cells.

21 January 2018

1 reference

Current directions for COX-2 inhibition in breast cancer

21 January 2018

1 reference

Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans

21 January 2018

1 reference

Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth

21 January 2018

1 reference

Resveratrol: a review of preclinical studies for human cancer prevention

21 January 2018

1 reference

The role of 11beta-hydroxysteroid dehydrogenase in metabolic disease and therapeutic potential of 11beta-hsd1 inhibitors

21 January 2018

1 reference

Adipose tissue as target organ in the treatment of hormone-dependent breast cancer: new therapeutic perspectives

21 January 2018

1 reference

Nutritional support and tumour growth in humans: a narrative review of the literature

21 January 2018

1 reference

Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study

21 January 2018

1 reference

Dietary patterns, risk and prognosis of breast cancer

21 January 2018

1 reference

Primary prevention of colorectal cancer

21 January 2018

1 reference

Current concepts in colorectal cancer prevention

21 January 2018

1 reference

Local recruitment experience in a study comparing the effectiveness of a low glycaemic index diet with a low calorie healthy eating approach at achieving weight loss and reducing the risk of endometrial cancer in women with polycystic ovary syndrome

21 January 2018

1 reference

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.

21 January 2018

1 reference

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

21 January 2018

1 reference

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

21 January 2018

1 reference

If mammalian target of metformin indirectly is mammalian target of rapamycin, then the insulin-like growth factor-1 receptor axis will audit the efficacy of metformin in cancer clinical trials

21 January 2018

1 reference

Metformin, insulin, breast cancer and more...

21 January 2018

1 reference

Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer

21 January 2018

1 reference

Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy

21 January 2018

1 reference

Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer

21 January 2018

1 reference

Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FON.10.87

1 reference

23 August 2017

1 reference

PubMed ID

20799876